Peptide Therapeutics is the fastest growing segment fueling growth of the Peptide Therapeutics Market
The global Peptide Therapeutics Market is estimated to be valued at US$ 44,386.9 Mn in 2023 and is expected to exhibit a CAGR of 6.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Peptide therapeutics are short chains of amino acids linked by peptide (amide) bonds. They can be used as alternatives to conventional small molecule drugs due to their high potency, specificity and low toxicity. They are used to treat conditions such as cancer, metabolic disorders, cardiovascular diseases etc. Market key trends: One of the key trends in the peptide therapeutics market size is the rising investment in R&D of novel peptide drugs. Peptide-based drugs have advantages over small molecules such as higher target specificity and lower toxicity. Major players are investing heavily in development of novel peptide drugs for various indications. For instance, Amgen invested around $5 billion in 2019 on R&D activi...